1,1,1,2-TETRABROMOETHANE (CID 61179) - BioAssay Data Summary for Compound
.
BioActivity Outcomes:
Active(166)
 
 
Inactive(434)
 
 
Inconclusive(52)
 
 
Unspecified(4)
 
 
Top Targets:
7TM GPCR Srx(14)
 
 
7TM GPCR Srsx(6)
 
 
NR LBD PPAR(5)
 
 
 
Peptidase C48(4)
 
 
BRLZ(4)
 
 
 
BioAssay Types:
Screening(244)
 
 
Confirmatory(229)
 
 
 
 
 
Literature(6)
 
 
BioActivity Types:
Potency(183)
 
 
 
 
 
IC50(8)
 
 
SAR
Target summary
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 485    Data Row: 656   Total Pages: 14   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID17389492]
Potency 1.9953qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory]aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681]
View
2
[SID17389492]
Potency 1.9953qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory]aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681]
View
3
[SID17389492]
Potency 7.9433Cell Viability - LYMP2-022 [AID987, Type: confirmatory]
View
4
[SID49731941]
Potency 9.2qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory]TDP1 protein [Homo sapiens] [gi:79154014]
View
5
[SID49731941]
Potency 9.2qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory]TDP1 protein [Homo sapiens] [gi:79154014]
View
6
[SID49731941]
Potency 9.2qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory]TDP1 protein [Homo sapiens] [gi:79154014]
View
7
[SID17389492]
Potency 12.5893Cell Viability - LYMP2-024 [AID988, Type: confirmatory]
View
8
[SID17389492]
Potency 12.5893Cell Viability - LYMP2-010 [AID981, Type: confirmatory]
View
9
[SID17389492]
Potency 12.5893Cell Viability - LYMP2-012 [AID982, Type: confirmatory]
View
10
[SID17389492]
Potency 12.5893Cell Viability - LYMP2-007 [AID979, Type: confirmatory]
View
11
[SID17389492]
Potency 15.8489Cell Viability - LYMP2-006 [AID978, Type: confirmatory]
View
12
[SID17389492]
Potency 15.8489Cell Viability - LYMP2-015 [AID971, Type: confirmatory]
View
13
[SID17389492]
Potency 15.8489Cell Viability - LYMP2-017 [AID972, Type: confirmatory]
View
14
[SID17389492]
Potency 15.8489Cell Viability - LYMP2-020 [AID986, Type: confirmatory]
View
15
[SID17389492]
Potency 19.9526Cell Viability - LYMP2-021 [AID974, Type: confirmatory]
View
16
[SID17389492]
Potency 19.9526Cell Viability - LYMP2-023 [AID975, Type: confirmatory]
View
17
[SID17389492]
Potency 25.1189Cell Viability - LYMP2-013 [AID970, Type: confirmatory]
View
18
[SID17389492]
Potency 29.8493qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory]NFE2L2 gene product [Homo sapiens] [gi:20149576]
View
19
[SID17389492]
Potency 29.8493qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory]NFE2L2 gene product [Homo sapiens] [gi:20149576]
View
20
[SID17389492]
Potency 29.8493qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory]NFE2L2 gene product [Homo sapiens] [gi:20149576]
View
21
[SID17389492]
Potency 29.8493qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory]NFE2L2 gene product [Homo sapiens] [gi:20149576]
View
22
[SID17389492]
Potency 31.6228Cell Viability - LYMP2-009 [AID968, Type: confirmatory]
View
23
[SID17389492]
Potency 39.8107Cell Viability - LYMP2-011 [AID969, Type: confirmatory]
View
24
[SID17389492]
Potency 39.8107Cell Viability - LYMP2-008 [AID980, Type: confirmatory]
View
25
[SID17389492]
Potency 42.1632qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion [AID651758, Type: confirmatory]interleukin 8 [Homo sapiens] [gi:186368]
View
26
[SID17389492]
Potency 42.1632qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion [AID651758, Type: confirmatory]interleukin 8 [Homo sapiens] [gi:186368]
View
27
[SID17389492]
Potency 42.1632qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion [AID651758, Type: confirmatory]interleukin 8 [Homo sapiens] [gi:186368]
View
28
[SID17389492]
 qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838_6, Type: other]
View
29
[SID17389492]
 qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838_7, Type: other]
View
30
[SID17389492]
 Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_21, Type: other]
View
31
[SID17389492]
 Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_22, Type: other]
View
32
[SID17389492]
 Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_23, Type: other]
View
33
[SID17389492]
 Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_24, Type: other]
View
34
[SID17389492]
 Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_25, Type: other]
View
35
[SID17389492]
 Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_26, Type: other]
View
36
[SID17389492]
 Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_27, Type: other]
View
37
[SID17389492]
 Cellular Toxicity (caspase-3) SK-N-SH [AID661, Type: confirmatory]
View
38
[SID17389492]
 Cell Viability - Jurkat [AID426, Type: confirmatory]
View
39
[SID17389492]
 Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_4, Type: other]
View
40
[SID17389492]
 Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_5, Type: other]
View
41
[SID17389492]
 Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_6, Type: other]
View
42
[SID17389492]
 Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_7, Type: other]
View
43
[SID17389492]
 Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_8, Type: other]
View
44
[SID17389492]
 Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_9, Type: other]
View
45
[SID17389492]
 Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_10, Type: other]
View
46
[SID17389492]
 Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_11, Type: other]
View
47
[SID17389492]
 Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_12, Type: other]
View
48
[SID17389492]
 Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_13, Type: other]
View
49
[SID17389492]
 Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_14, Type: other]
View
50
[SID17389492]
 Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_15, Type: other]
View